Human-derived bacterial strains mitigate colitis via modulating gut microbiota and repairing intestinal barrier function in mice
BMC Microbiology · 2024
DOI: 10.1186/s12866-024-03216-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Microbiology, 2024. Verfasst von Juanjuan Dai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen …. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Colitis, Colitis, Ulcerative, Enterococcus faecium. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Shanghai General Hospital.
Abstract (Originalsprache)
Background
Unbalanced gut microbiota is considered as a pivotal etiological factor in colitis. Nevertheless, the precise influence of the endogenous gut microbiota composition on the therapeutic efficacy of probiotics in colitis remains largely unexplored.
Results
In this study, we isolated bacteria from fecal samples of a healthy donor and a patient with ulcerative colitis in remission. Subsequently, we identified three bacterial strains that exhibited a notable ability to ameliorate dextran sulfate sodium (DSS)-induced colitis, as evidenced by increased colon length, reduced disease activity index, and improved histological score. Further analysis revealed that each of Pediococcus acidilactici CGMCC NO.17,943, Enterococcus faecium CGMCC NO.17,944 and Escherichia coli CGMCC NO.17,945 significantly attenuated inflammatory responses and restored gut barrier dysfunction in mice. Mechanistically, bacterial 16S rRNA gene sequencing indicated that these three strains partially restored the overall structure of the gut microbiota disrupted by DSS. Specially, they promoted the growth of Faecalibaculum and Lactobacillus murinus , which were positively correlated with gut barrier function, while suppressing Odoribacter , Rikenella , Oscillibacter and Parasutterella , which were related to inflammation. Additionally, these strains modulated the composition of short chain fatty acids (SCFAs) in the cecal content, leading to an increase in acetate and a decrease in butyrate. Furthermore, the expression of metabolites related receptors, such as receptor G Protein-coupled receptor (GPR) 43, were also affected. Notably, the depletion of endogenous gut microbiota using broad-spectrum antibiotics completely abrogated these protective effects.
Conclusions
Our findings suggest that selected human-derived bacterial strains alleviate experimental colitis and intestinal barrier dysfunction through mediating resident gut microbiota and their metabolites in mice. This study provides valuable insights into the potential therapeutic application of probiotics in the treatment of colitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Intensive Care Unit, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P.R. China.
- Department of Head and Neck Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P.R. China.
- Shanghai Key Laboratory of Pancreatic Diseases, Institute of Translational Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Stomatology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. shiyiwll@163.com.
- Shanghai Key Laboratory of Pancreatic Diseases, Institute of Translational Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. wangjingjing6891@163.com.
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Shanghai General Hospital
Zitieren
APA
Dai, J., Jiang, M., Wang, X., Lang, T., Wan, L., & Wang, J. (2024). Human-derived bacterial strains mitigate colitis via modulating gut microbiota and repairing intestinal barrier function in mice. BMC Microbiology. https://doi.org/10.1186/s12866-024-03216-5
Vancouver
Dai J, Jiang M, Wang X, Lang T, Wan L, Wang J. Human-derived bacterial strains mitigate colitis via modulating gut microbiota and repairing intestinal barrier function in mice. BMC Microbiology. 2024. doi:10.1186/s12866-024-03216-5
BibTeX
@article{Dai2024,
author = {Dai, Juanjuan and Jiang, Mingjie and Wang, Xiaoxin and Lang, Tao and Wan, Leilei and Wang, Jingjing},
title = {Human-derived bacterial strains mitigate colitis via modulating gut microbiota and repairing intestinal barrier function in mice},
journal = {BMC Microbiology},
year = {2024},
doi = {10.1186/s12866-024-03216-5}
}
EUVIMED